GetPortalImpactFactorByIdResp(projectId=1, id=514a7640, cover=https://img.medsci.cn/images/journal/cover/2021/zEV_202109271316187690.jpg, fullname=Personalized Medicine, abbr=PERS MED, pyear=2004, frequence=Bimonthly, articleNumbers=439, citedSelf2015=18.6, acceptanceRate=null, submissionToAcceptance=null, averageReviewTime=平均1月, reviewFee=null, pageFee=null, publishedRatio=2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%), issn=1741-0541, greenSci=https://www.greensci.net/search?kw=1741-0541, scijournal=https://www.scijournal.org/impact-factor-of-PERS-MED.shtml, medsciHotlightString=null, medsciHotlightRealtime=2.408, medsciHotlight=2.648, medsciHotlight5year=3.39565, citescore=3.3, hIndex=31, impactFactor=2.3, orgnization=Future Medicine Ltd., orgnizationUrl=http://futuremedicine.com/, country=United Kingdom, countryCn=英国, isOa=1, isOaString=是, sciScie=Science Citation Index Expanded|Current Contents - Clinical Medicine, bigclassCas=医学 4区, smallclassCas=医学 4 区, website=http://www.futuremedicine.com/loi/pme, websiteHits=4359, guideForAuthor=https://www.futuremedicine.com/authorguide, guideForAuthorHits=619, submitWebsite=https://mc04.manuscriptcentral.com/fm-pme, submitWebsiteHits=1378, content=Personalized Medicine (ISSN 1741-0541) translates recent genomic, genetic and proteomic advances into the clinical context. The journal provides an integrated forum for all players involved - academic and clinical researchers, pharmaceutical companies, regulatory authorities, healthcare management organizations, patient organizations and others in the healthcare community. Personalized Medicine assists these parties to shape the future of medicine by providing a platform for expert commentary and analysis. The journal addresses scientific, commercial and policy issues in Personalized Medicine and includes news and views, current awareness regarding new biomarkers, concise commentary and analysis, reports from the conference circuit and full review articles. Articles submitted to Personalized Medicine are subject to rigorous peer review. Topics addressed include: Advances in molecular diagnostics; Biochip/microarray technologies; Biological therapies or vaccine approaches at specific genetic and immunologic targets; Cost-benefit issues for personalized medicine; Ethics in personalized medicine; Impact of personalized medicine on healthcare and the pharmaceutical industry; Impact of the latest concepts of development of personalized medicine based on pharmacogenomics, pharmacogenetics and pharmacoproteomics; Incorporation of genetic analysis in clinical trials methodology; Integration of diagnosis with therapy; Prediction of adverse reactions of drugs and drug safety; Treatment monitoring., totalCites=1010, brief=PERS MED杂志医学行业，“<strong><a target="_blank" href="/sci/index.do?smallclass=药学" >药学</a></strong>”子行业的偏低级别杂志, articleType=本刊接收类型不明, medsciHeat=<span style="color: #000000;">黑</span>, medsciComment=杂志水平一般，也很冷门，关注人少，审稿周期可能也不一定快，如果文章质量不佳，或时间不紧的话，可以考虑考虑。, medsciExplanation=MedSci期刊指数是根据中国科研工作者（含医学临床，基础，生物，化学等学科）对SCI杂志的认知度，熟悉程度，以及投稿的量等众多指标综合评定而成。当然，具体的，您还可以结合“<a href='//m.capotfarm.com/sci/submit.do?id=514a7640'>投稿经验系统</a>”，进行综合判断，这更是大家的实战经验，值得分享和参考。<br> 注意，上述MedSci期刊指数采用MedSci专利技术，由计算机系统自动计算，并给出建议，存在不准确的可能，仅供您投稿选择杂志时参考。, tags=[ImpactFactorTagDto(id=7990, tagName=测序, createdHits=1), ImpactFactorTagDto(id=119, tagName=肿瘤, createdHits=1), ImpactFactorTagDto(id=313, tagName=临床, createdHits=1), ImpactFactorTagDto(id=1662, tagName=生物标志物, createdHits=1), ImpactFactorTagDto(id=8375, tagName=慢性肝病, createdHits=1)], citeScoreList=[GetImpactFactorCiteScoreListResponse(year=2017, citescore=0.88), GetImpactFactorCiteScoreListResponse(year=2018, citescore=0.83), GetImpactFactorCiteScoreListResponse(year=2019, citescore=2.1), GetImpactFactorCiteScoreListResponse(year=2020, citescore=3.1), GetImpactFactorCiteScoreListResponse(year=2023, citescore=3.3)], medsciIndexList=[GetImpactFactorMedsciIndexListResponse(year=2020, medsciHotlight=2.768), GetImpactFactorMedsciIndexListResponse(year=2021, medsciHotlight=2.656), GetImpactFactorMedsciIndexListResponse(year=2022, medsciHotlight=2.439), GetImpactFactorMedsciIndexListResponse(year=2023, medsciHotlight=2.215), GetImpactFactorMedsciIndexListResponse(year=2024, medsciHotlight=2.408)], citeScoreGradeList=[GetImpactFactorCiteScoreGradeResponse(smallClass=Pharmacology, Toxicology and Pharmaceutics - Pharmacology , rank=219/300), GetImpactFactorCiteScoreGradeResponse(smallClass=Biochemistry, Genetics and Molecular Biology - Molecular Medicine , rank=145/165)], totalJcrAreaList=[GetImpactFactorCiteScoreGradeResponse(smallClass=PHARMACOLOGY & PHARMACY, rank=Q4)], pmcUrl=https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1741-0541[ISSN], pubmedUrl=https://www.ncbi.nlm.nih.gov/pubmed?cmd=search&term=PERSONALIZED MEDICINE[ta], article_number=37, article_number_cn=3, earlyWarning=中科院风险预警（2021）：低, linkOutUrl=null, isJournalMember=false, unscrambleContent=null, dayViewCount=false, endexampletyle=暂无数据)